OFD + ALN

OFD + ALN is a combination drug consisting of two active pharmaceutical ingredients. "ALN" refers to alendronate, a bisphosphonate used primarily for the treatment and prevention of osteoporosis by inhibiting osteoclast-mediated bone resorption, thereby increasing bone mineral density[2][5][7]. The identity of "OFD" is unclear based on available sources; it does not correspond to any widely recognized pharmaceutical abbreviation or agent in the context of osteoporosis or related conditions. No evidence was found for an approved or investigational combination product specifically named "OFD + ALN." Alendronate is commonly combined with vitamin D (cholecalciferol) in marketed products, but not with an agent abbreviated as OFD[2][8]. Therefore, this entry likely refers to a research code name or an unrecognized/incorrect abbreviation.